Masimo

Traded on the St. Petersburg Stock Exchange
Masimo is a global medical technology company that develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation solutions, home monitoring devices, ventilation solutions, and consumer products.
Masimo stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Masimo balance sheet

Report period2018 2019 2020 2021 2022 Q2 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Masimo cash flows

Report period2018 2019 2020 2021 2022 Q2 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Masimo multipliers

Report period2018 2019 2020 2021 2022 Q2 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Masimo profitability

Report period2018 2019 2020 2021 2022 Q2 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Masimo assets
Masimo cash flows

Masimo shares

TickerNameTypeNominal valueISINPrice
MASI:USMasimo Corp.Common share-US5747951003$134.9
Masimo news
04.05.2022
Masimo's GAAP net income for 3 months of 2022 was $46.595 million, down 12.7% from $53.383 million in the previous year. Revenue increased 1.7% to $304.241 million from $299.043 million a year earlier.
16.02.2022
Masimo's GAAP net income for 2021 was $229.647 million, down 4.4% from $240.282 million in the previous year. Revenues rose 8.3% to $1.239 billion from $1.144 billion a year earlier.
27.10.2021
Masimo's GAAP net income for the nine months of 2021 was $161.389 million, down 4.9% from $169.633 million in the previous year. Revenues increased 7.4% to $911.575 million from $848.69 million a year earlier.
28.07.2021
Masimo's GAAP net income for the six months of 2021 was $103.618 million, down 13.8% from $120.228 million in the previous year. Revenue increased 5.9% to $604.161 million from $570.578 million a year earlier.
General information
Company nameMasimo
Tags#medtech
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment
Business address52 DISCOVERY IRVINE CA 92618 949-297-7000
Mailing address52 DISCOVERY IRVINE CA 92618
Websitewww.masimo.com
Information disclosurewww.sec.gov